EcoDrugPlus

Progesterone Receptor-Like

Ensembl ID : ENSSLUG00000024872
Gene Symbol: LOC116036548
2 Cross references
206 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSLUG00000001899
Gene Symbol: PTGDR2
1 Cross references
135 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSLUG00000008216
Gene Symbol: PTGDR2
1 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSSLUG00000025868
Gene Symbol: PTGER2
3 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSSLUG00000025590
Gene Symbol: PTGER3
1 Cross references
194 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSSLUG00000019765
Gene Symbol: LOC116039535
3 Cross references
167 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSSLUG00000022611
Gene Symbol: LOC116046749
3 Cross references
164 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSSLUG00000022794
Gene Symbol: LOC116054045
3 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSSLUG00000021443
Gene Symbol: LOC116062977
3 Cross references
201 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSSLUG00000020412
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSSLUG00000011390
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSSLUG00000008306
Gene Symbol: PTGS1
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).